DOI: 10.4244/EIJ-D-20-00924L

Letter: How should coronary computed tomography angiography co-registration be applied in the chronic total occlusion hybrid algorithm?

Maksymilian P. Opolski1, MD, PhD; Paul Knaapen1, MD, PhD

We read with great interest the paper by Xenogiannis et al regarding their initial experience with real-time coronary computed tomography angiography (coronary CTA)/fluoroscopy fusion guidance for chronic total occlusion (CTO) percutaneous coronary intervention (PCI)1. While their observations are interesting, we would like to raise some important points regarding the practical use of CTA co-registration for CTO PCI using the hybrid algorithm.

First, whereas the second most common indication (56%) for CTA/fluoroscopy fusion in the study by Xenogiannis et al was to facilitate intra-CTO wire advancement, coronary CTA cannot reliably differentiate between intraluminal and subintimal guidewire position2. Specifically, the spatial resolution of current-generation CT scanners of about 0.5 mm (not to mention motion, partial volume effect and beam hardening) does not guarantee adequate imaging of the small and moving metallic objects relative to the coronary vessel wall3. Conversely, the entirety of information proffered by guidewire tip appearance and operator tactile feedback, in conjunction with intravascular ultrasound which allows improved spatial imaging (100-200 µm), usually suffices for precise guidewire localisation during CTO PCI.

Second, although real-time fusion of CTA with X-ray fluoroscopy represents a fancy and eye-pleasing technique, it is still hampered by patient, respiratory and cardiac motion artefacts resulting in a relatively wide margin of registration errors, thus compromising the submillimetric precision required for CTO PCI2. In addition, the colour-coded lines of CTA embedded within the real-time fluoroscopic environment may potentially obscure the exact visualisation of the CTO toolkit, and thus paradoxically reduce the efficiency of CTO PCI. Hence, in our experience, the computationally less intense approach of CTA co-registration on separate monitors in the catheterisation laboratory (equally available with automatic software tools) can provide new insights into CTO visualisation without suffering from the limitations of the fusion technique.

Finally, it should be stated explicitly that the biggest advantage of CTA during CTO PCI relies on clear visualisation of the proximal cap and distal CTO segment including the extent and severity of calcifications (a phenomenon not readily obtainable from invasive angiography)2. Consequently, periprocedural display of CTA is invariably suited to clarifying proximal cap ambiguity and selecting the most optimal re-entry site, both of which might have far-reaching implications for improving the efficiency and success rate of antegrade and dissection re-entry (ADR) with a potential for reducing the need for the retrograde approach. This was indeed reflected in the study by Xenogiannis et al, in which ADR was the most common successful crossing strategy (37%) in the CTA/fluoroscopy fusion group1. While this finding might be equally well explained by the relatively high number of prior CTO PCI attempts (37%), the information on the success rate of ADR under CTA guidance (and its comparison to prior data on angiography-guided ADR) would be highly appreciated.

The study by Xenogiannis et al is a stimulating but hypothesis-generating report. The wider application of coronary CTA for CTO PCI is highly dependent on its successful implementation into the hybrid algorithm, in which two features, namely the proximal cap and distal target, should play a major role.

Conflict of interest statement

P. Knaapen has received research grants from HeartFlow. M.P. Opolski has no conflicts of interest to declare.

Supplementary data

To read the full content of this article, please download the PDF.

Volume 16 Number 16
Mar 19, 2021
Volume 16 Number 16
View full issue


Key metrics

Trending articles
310.18

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
72.85

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved